How big is the in-vitro toxicology testing market?

The global in-vitro toxicology testing market size was estimated at USD 31.03 billion in 2023 and is expected to reach USD 34.33 billion in 2024.

What is the in-vitro toxicology testing market growth?

The global in-vitro toxicology testing market is expected to grow at a compound annual growth rate of 11.17% from 2024 to 2030 to reach USD 64.81 billion by 2030.

Which segment accounted for the largest in-vitro toxicology testing market share?

Cell culture technology dominated the in-vitro toxicology testing market with a share of 43.88% in 2023 due to its ability to serve as an excellent model for examining toxic effects on cells in a reproducible manner.

Who are the key players in the in-vitro toxicology testing market?

Some key players operating in the in-vitro toxicology testing market include Merck KGaA; Charles River; Bio-Rad Laboratories, Inc.; Abbott; Thermo Fisher Scientific Inc.; Catalent, Inc.; GE Healthcare; Quest Diagnostics Incorporated; Eurofins Scientific; Laboratory Corporation of America Holdings; Evotec; Creative Bioarray; Gentronix; BioIVT; SGS SA; and Agilent Technologies.

What are the factors driving the in-vitro toxicology testing market?

Key factors that are driving the in-vitro toxicology testing market growth include the rise in government funding for toxicology research, opposition to animal testing, and ongoing developments to advance toxicology research.